cyproheptadine has been researched along with Autistic Disorder in 2 studies
Cyproheptadine: A serotonin antagonist and a histamine H1 blocker used as antipruritic, appetite stimulant, antiallergic, and for the post-gastrectomy dumping syndrome, etc.
cyproheptadine : The product resulting from the formal oxidative coupling of position 5 of 5H-dibenzo[a,d]cycloheptene with position 4 of 1-methylpiperidine resulting in the formation of a double bond between the two fragments. It is a sedating antihistamine with antimuscarinic and calcium-channel blocking actions. It is used (particularly as the hydrochloride sesquihydrate) for the relief of allergic conditions including rhinitis, conjunctivitis due to inhalant allergens and foods, urticaria and angioedema, and in pruritic skin disorders. Unlike other antihistamines, it is also a seratonin receptor antagonist, making it useful in conditions such as vascular headache and anorexia.
Autistic Disorder: A disorder beginning in childhood. It is marked by the presence of markedly abnormal or impaired development in social interaction and communication and a markedly restricted repertoire of activity and interest. Manifestations of the disorder vary greatly depending on the developmental level and chronological age of the individual. (DSM-V)
| Excerpt | Relevance | Reference |
|---|---|---|
| "The ABC-C and the Childhood Autism Rating Scale scores improved with cyproheptadine." | 9.11 | Cyproheptadine in the treatment of autistic disorder: a double-blind placebo-controlled trial. ( Akhondzadeh, S; Amini, H; Erfani, S; Gudarzi, SS; Mohammadi, MR; Tehrani-Doost, M; Yasamy, MT, 2004) |
| "The ABC-C and the Childhood Autism Rating Scale scores improved with cyproheptadine." | 5.11 | Cyproheptadine in the treatment of autistic disorder: a double-blind placebo-controlled trial. ( Akhondzadeh, S; Amini, H; Erfani, S; Gudarzi, SS; Mohammadi, MR; Tehrani-Doost, M; Yasamy, MT, 2004) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Gudarzi, SS | 2 |
| Yasamy, M | 1 |
| Akhondzadeh, S | 2 |
| Erfani, S | 1 |
| Mohammadi, MR | 1 |
| Tehrani-Doost, M | 1 |
| Amini, H | 1 |
| Yasamy, MT | 1 |
1 trial available for cyproheptadine and Autistic Disorder
| Article | Year |
|---|---|
Cyproheptadine in the treatment of autistic disorder: a double-blind placebo-controlled trial.
Topics: Autistic Disorder; Basal Ganglia Diseases; Child; Child, Preschool; Cyproheptadine; Double-Blind Met | 2004 |
1 other study available for cyproheptadine and Autistic Disorder
| Article | Year |
|---|---|
Cyproheptadine in treatment of autism.
Topics: Adolescent; Autistic Disorder; Cyproheptadine; Female; Humans; Male; Serotonin Antagonists | 2002 |